<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: The transcription factor upstream stimulatory factor 1 (USF1) regulates the expression of genes involved in <z:chebi fb="105" ids="17234">glucose</z:chebi> and <z:chebi fb="23" ids="18059">lipid</z:chebi> metabolism and has been associated with <z:e sem="disease" ids="C0020474,C1704417" disease_type="Disease or Syndrome" abbrv="">familial combined hyperlipidaemia</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>USF1 is located on chromosome 1q22-23, a region with evidence for linkage to type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and various traits of the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> in Chinese and other populations </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of this study was to investigate the linkage and association of USF1 with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> in Chinese individuals </plain></SENT>
<SENT sid="3" pm="."><plain>MATERIALS AND METHODS: We genotyped three haplotype-tagging single nucleotide polymorphisms (SNPs) (rs3737787, rs2516841 and rs2516839) at USF1 in three samples of the Hong Kong Chinese population, including members of 179 families from the Hong Kong Family <z:mp ids='MP_0002055'>Diabetes</z:mp> Study, 1,383 hospital cases with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and/or the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> and 454 <z:mpath ids='MPATH_458'>normal</z:mpath> control subjects </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: We found significant association of individual polymorphisms and haplotypes with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and/or <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e>-related traits in the family samples using either family-based or unrelated <z:mpath ids='MPATH_458'>normal</z:mpath> control subjects </plain></SENT>
<SENT sid="5" pm="."><plain>However, these variants could not explain much of the evidence for linkage in this region </plain></SENT>
<SENT sid="6" pm="."><plain>Moreover, they were not associated with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and/or the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> in the hospital cases </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS/INTERPRETATION: The results are consistent with the hypothesis that variation at USF1 contributes to the risk of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> in families with strong evidence for linkage in the chromosome 1q region </plain></SENT>
<SENT sid="8" pm="."><plain>However, they provide little support for USF1 as the susceptibility locus that generates the observed evidence for linkage at 1q21-25 for type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and/or the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e>, and USF1 does not appear to have a major contribution to these phenotypes in the general Chinese population </plain></SENT>
</text></document>